AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2014

Nov 10, 2014

5229_dirs_2014-11-10_898b0849-b3de-459a-92c8-ea928db103b0.html

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6085W

AstraZeneca PLC

10 November 2014

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 10 November 2014, Luke Miels, EVP, Global Product and Portfolio Strategy, a person discharging managerial responsibilities, notified us that, on 7 November 2014, Mrs Jane Miels, a person connected with him, purchased 10,500 AstraZeneca PLC Ordinary Shares of $0.25 each at a price of 4614.5 pence per share.

A C N Kemp

Company Secretary

10 November 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSURVORSKAAAAA